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ARTICLE
Recurrent Reciprocal Genomic Rearrangements of 17q12
Are Associated with Renal Disease, Diabetes, and Epilepsy
Heather C. Mefford, Se´verine Clauin, Andrew J. Sharp, Rikke S. Moller, Reinhard Ullmann,
Raj Kapur, Dan Pinkel, Gregory M. Cooper, Mario Ventura, H. Hilger Ropers, Niels Tommerup,
Evan E. Eichler, and Christine Bellanne-Chantelot
Most studies of genomic disorders have focused on patients with cognitive disability and/or peripheral nervous system
defects. In an effort to broaden the phenotypic spectrum of this disease model, we assessed 155 autopsy samples from
fetuses with well-defined developmental pathologies in regions predisposed to recurrent rearrangement, by array-based
comparative genomic hybridization. We found that 6% of fetal material showed evidence of microdeletion or micro-
duplication, including three independent events that likely resulted from unequal crossing-over between segmental
duplications. One of the microdeletions, identified in a fetus with multicystic dysplastic kidneys, encompasses the TCF2
gene on 17q12, previously shown to be mutated in maturity-onset diabetes, as well as in a subset of pediatric renal
abnormalities. Fine-scale mapping of the breakpoints in different patient cohorts revealed a recurrent 1.5-Mb de novo
deletion in individuals with phenotypes that ranged from congenital renal abnormalities to maturity-onset diabetes of
the young type 5. We also identified the reciprocal duplication, which appears to be enriched in samples from patients
with epilepsy. We describe the first example of a recurrent genomic disorder associated with diabetes.
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Genomic disorders result from nonallelic homologous re-
combination (NAHR) between low-copy repeats and occur
in ∼1 in 1,000 live births.1 The phenotypes of many of
the known genomic disorders include developmental de-
lay and mental retardation (e.g., velocardiofacial syn-
drome, Williams-Beurens syndrome, and Smith-Magenis
syndrome). Therefore, many of the large screens for novel
genomic disorders have focused on individuals with men-
tal retardation.2–7 Previously, we developed a BAC array
targeted to 130 “rearrangement hotspots,” defined as
regions of the genome with an architecture suggestive of
a susceptibility to recurrent microdeletion and/or dupli-
cation. Use of this array to evaluate 316 unaffected
individuals8,9 and 290 individuals with idiopathic mental
retardation7 resulted in the identification of copy-number
polymorphisms, as well as novel genomic disorders.
Interestingly, despite an architecture that predicts a sus-
ceptibility to rearrangement, many of these 130 hotspot
regions have never been observed as a copy-number var-
iant in the unaffected and developmentally delayed in-
dividuals studied. We hypothesized that these “invariant”
regions contain genes essential for normal morphogenesis
and are involved in pathways other than those critical for
normal cognitive development. To test this hypothesis,
we evaluated DNA from fetal samples with one or more
congenital anomalies for which the pathology was well
documented. We reasoned that rearrangements resulting
in major malformations or incompatibility with life would
be found in such prenatal cases. We show here that one
of these microdeletions associated with a fetal sample with
grossly abnormal, dysplastic multicystic kidneys is the re-
sult of a recurrent rearrangement of 17q12 mediated by
segmental duplications. De novo deletions with identical
breakpoints are found in living patients with a range of
phenotypes, from those with renal abnormalities10,11 to
individuals whose primary diagnosis is maturity-onset di-
abetes of the young type 5 (MODY5 [MIM 137920]).12 This
is the first example of a recurrent genomic disorder as-
sociated with diabetes and one of the few examples of a
contiguous gene-deletion syndrome without mental re-
tardation. We also discovered the reciprocal duplication
in individuals with epilepsy and/or mental retardation,
as well as in unaffected individuals. These data suggest
considerable variability in expressivity of the phenotype
and widen the spectrum of diseases caused by genomic
disorders.
Material and Methods
DNA Samples
DNA samples were obtained from prenatal autopsy specimens
( ) and from individuals with renal disease and/or MODY5,np 155
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Figure 1. Recurrent microdeletion of 17q12. a, Kidney photographs from case FA-275, showing multiple cysts bilaterally with en-
largement of the left kidney, hypoplastic bladder, and atresia of the left ureter. b, BAC array data for case FA-275, showing deletion
of a chromosomal region represented by seven chromosome 17 BAC clones. c, Structural resolution of a 1.5-Mb microdeletion region
of 17q12 by use of a high-density oligonucleotide microarray. Eight of the nine cases have proximal and distal breakpoints mapping
to flanking segmental duplications. Plots show the log2 ratio (Y-axis) for 48,256 probes (X-axis) in this region of 17q12 (hg17 coordinates
chr17:31200000–33850000). For each individual, deviations of probe log2 ratios from zero are depicted by gray and black lines, with
those exceeding a threshold of 0.9 SDs (duplications) and 1.5 SDs (deletions) from the mean probe ratio colored green and red to
represent relative gains and losses, respectively. Bars define regions of copy-number variation (shaded gray) in controls and common
recurrent deletion (shaded pink).
with the appropriate institutional-review-board approval. Fetal
liver tissue was obtained from Children’s Hospital and Regional
Medical Center. All samples were from fetuses that underwent
autopsy after elective termination or fetal demise between 1995
and 2006. DNA was extracted using Gentra PureGene DNA ex-
traction kit. The renal pediatric and MODY5 cases represent pa-
tients who were analyzed previously for TCF2 molecular abnor-
malities.10–12 Two control groups were used to assess the extent
of normal copy-number variation. The first control group con-
sisted of 316 unrelated individuals (HapMap and Diversity pop-
ulation) who had been tested using the same BAC duplication
microarray.8,9 A second control population, comprising 960 un-
related white adults (aged 40–70 years) from the United States,
was genotyped using the HumanHap300 Genotyping BeadChips
(Illumina), which consists of ∼317,000 HapMap SNPs spread
throughout the genome. Each individual was enrolled in the
Pharmacogenomics and Risk of Cardiovascular Disease (PARC)
study, which aims to identify genetic contributors to the variable
efficacy of statin drugs for cardiovascular disease (PharmGKB:
PARC Profile). Hybridizations, data analysis, and copy-number
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Figure 2. Structural resolution of additional rearrangements in the fetal autopsy series. a, A 157-kb duplication of chromosome 17q23
in FA-142, a fetus with multicystic dysplastic kidneys. Paired segmental duplications (seg dups) with 199% identity are indicated. Breakpoints
of this duplication are in CLTC (proximal) and TMEM49 (distal). PTHR2 (BIT1) is entirely within the duplicated region. b, A 2.5-Mb microdeletion
of chromosome 15q25.2 (hg17 coordinates chr15:81011700–83540700) in FA-602, a fetus with congenital diaphragmatic hernia and mild
hydrocephalus. c, A 2-Mb deletion of 16p13.12-p12.3 in FA-180 (hg17 coordinates chr16:14200000–17200000). Regions of known copy-
number polymorphism (CNP) in unaffected individuals are indicated (blue bars). Plots show the log2 ratio (Y-axis) for probes (X-axis) in
the region depicted. Deviations of probe log2 ratios from zero are depicted as in figure 1c.
analysis, with particular reference to chromosome 17q12 (137
probes within the critical region), were performed according to
published protocols.13
Array-Based Comparative Genomic Hybridization
(Array CGH)
DNA was hybridized to a custom BAC array consisting of 2,007
clones targeted to regions of the genome flanked by segmental
duplications, as described elsewhere.9 This array includes all
regions associated with known genomic disorders and an addi-
tional ∼105 regions with similar genomic architecture. Because
of the targeted nature of this array, we will not detect rearrange-
ments that are not mediated by segmental duplications. Regions
were scored as copy-number variant if the log2 ratio of two or
more consecutive clones each exceeded twice the SD of the au-
tosomal clones in dye-swap replicate experiments.7 We used a
whole-genome tiling path array containing 32,433 BAC clones14
or a custom oligonucleotide array (NimbleGen Systems), con-
sisting of 385,000 isothermal probes (length 45–75 bp) covering
several chromosomal regions, including a 3-Mb region of chro-
mosome 17q12 (55,888 probes; mean density 1 probe per 53 bp)
to refine the breakpoints. Hybridizations were performed as de-
scribed elsewhere,15 and a single unaffected male (GM15724 [Cor-
iell]) was used as reference. Oligonucleotide array data are avail-
able at the Human Genome Structural Variation Project Web site.
Quantitative PCR
Oligonucleotides for real-time quantitative PCR assays were se-
lected using Primer3 software.16 Primer sequences (5′r3′) for exon
1 primers are as follows: forward primer ATTTCCTGGTGCGAGT-
TTTG and reverse primer CAGGGGATGACTCCTGAAGA. PCRs
were performed in an LC480 machine (Roche) by use of SYBR
Green PCR Master Mix (Applied Biosystems). PCR conditions
were 95C for 5 min, followed by 40 cycles at 95C for 15 s, 55C
for 20 s, and 72C for 20 s. Reactions were performed in triplicate,
with a final reaction volume of 10 ml containing 10 ng DNA, 1.6
mM primer, and 5 ml SYBR Green Master Mix. Control primers
were placed in the albumin gene.
FISH
Metaphase spreads and nuclei were obtained from phytohemag-
glutinin-stimulated peripheral lymphocytes of individuals 6498
and 6840 by standard procedures. FISH experiments were per-
formed using fosmid WIBR2-6022g13 (NCBI May 2004 assembly
[hg17] coordinates chr17:32364308–32399464), directly labeled
by nick-translation with Cy3-dCTP (Perkin-Elmer), as described
elsewhere,17 with minor modifications. Fosmids WIBR2-3001A12
(hg17 coordinates chr17:32309158–32347025; not duplicated
in either case) and WIBR2-946N02 (hg17 coordinates chr17:
33156592–33197819; duplicated in both cases) were used in con-
trol experiments.
Results
Fetal Anomalies and Genomic Rearrangements
We evaluated 155 fetuses with one or more congenital
anomalies and no known cytogenetic abnormalities in
this study (128 with normal karyotype, 12 of whom also
had normal FISH results for 22q11 deletion, and 27 of
whom had no karyotype information reported). To min-
imize false-positive results, we focused on microdeletions
and microduplications defined by two or more adjacent
BAC clones on our targeted array that were not observed
as copy-number polymorphisms in 1400 control individ-
uals either on our BAC array platform8,9 or in studies of
full-tiling path microarrays.18,19 We identified nine indi-
viduals (6%) with detectable deletions or duplications,
eight of which may be pathogenic (table 1). Analysis using
whole-genome tiling-path BAC arrays or high-density
oligonucleotide arrays allowed refinement of the break-
points. Three of the alterations are microdeletions with
breakpoints in flanking segmental duplications: a 1.8-Mb
deletion at 17q12 in a fetus with multicystic renal dys-
plasia (FA-275 in fig. 1), a 2.5-Mb deletion at 15q25.2 in
a fetus with congenital diaphragmatic hernia and mild
hydrocephalus (fig. 2b), and a 2-Mb deletion at 16p13.11
in a fetus with posthemorrhagic hydrocephalus, cleft lip,
preauricular tags, and two cleft vertebrae (fig. 2c). In each
case, the regions flanking the microdeletions are poly-
morphic in copy number (on the basis of an analysis of
270 unaffected individuals). The smallest rearrangement
we detected was a 157-kb duplication (case FA-142 in fig.
2a).
MODY5: A Recurrent 17q12 Microdeletion Disorder
Case FA-275 represents a fetus with bilateral multicystic
renal dysplasia, bilateral ureteropelvic junction stenosis,
atretic right ureter, and hypoplastic bladder (fig. 1a). We
detected a deletion of seven BACs spanning nearly 2 Mb
of sequence on our targeted BAC array (fig. 1b). Fine map-
ping with a customized oligonucleotide array (average
probe spacing 53 bp) showed that the deleted region spans
1.8 Mb and involves 19 known genes, including CCL3L1
(MIM 601395), CCL4L1 (MIM 603782), and TBC1D3
(MIM 607741), which are present in multiple copies (fig.
1c). Because of copy-number polymorphism in the flank-
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Figure 3. Copy-number variation of the segmental duplications (Seg dups) at breakpoint regions. An expanded view of oligonucleotide
array CGH within the segmental duplications located at the proximal (left) and distal (right) breakpoints of 17q12 rearrangements.
Control set includes five unaffected individuals analyzed on same custom array as the patients with 17q12 deletion or duplication. For
each individual, deviations of probe log2 ratios from zero are depicted as in figure 1c. Control individuals show increased and decreased
copy number in the segmental duplications, highlighting the difficulty in determining precise rearrangement breakpoints. Individuals
shown are IMR379, 5812, 6498, FR12, FR92, FR09, FR37, C1, C2, C3, C4, and C5.
ing regions (figs. 3 and 4), it is difficult to predict the exact
breakpoints of the deletion; however, both proximal and
distal breakpoints are within segmental-duplication clus-
ters with multiple regions of high identity—the most
significant has 199% identity across 76 kb (hg17 coordi-
nates chr17:31808172–31883983 and chr17:33529232–
33604211).
The deleted region in case FA-275 includes the TCF2
gene (MIM 189907), mutations of which are known to
cause MODY5,20 as well as both pediatric11,21 and prena-
tally detectable10 cystic renal disease. One third of a series
of MODY5-affected individuals with TCF2 alterations
have deletions of the entire TCF2 gene and surrounding
sequence.12 Similar deletions have been found in pediatric
cystic renal disease.10,11,21 Because the deletion in case FA-
275 appeared to overlap the deletions reported in patients
with MODY5, we used oligonucleotide arrays to refine the
deletion breakpoints in five patients with pediatric renal
disease without diabetes and three patients with MODY5
(diabetes and renal disease) who had previously been
shown to have deletions encompassing the TCF2 gene
(table 2).
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Figure 4. Copy-number polymorphism of the segmental duplications at the breakpoint regions. An expanded view of figure 2, showing
eight additional control individuals (controls C6–C13) analyzed on a custom oligonucleotide array targeted to segmental duplications
(Seg dups) and five additional patients with 17q12 deletion. Controls C1–C5 are the same as in figure 2. For each individual, deviations
of probe log2 ratios from zero are depicted as in figures 1 and 2. The patients with 17q12 deletion shown are FR40, FR99, FR45, FR35,
and FA-275.
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Figure 5. Reciprocal 17q12 duplication. a, Structural resolution of the reciprocal 1.5-Mb microduplication region of 17q12 by use of
high-density oligonucleotide microarrays. Plots show the log2 ratio (Y-axis) for 48,256 probes (X-axis) in this region of 17q12 (hg17
coordinates chr17:31200000–33850000). Three affected individuals with mental retardation and epilepsy and the unaffected mother
of 6498 are shown. An expanded view of the LHX1 region (hg17 coordinates chr17:32325000–32345000) is also shown for individuals
6498 and 6840. The average log2 ratio for the 765 probes in the 27-kb region (dotted lines) is 0.176 for individual 6498 and 0.030 for
individual 6840 (the mother). c, Quantitative PCR results for exon 1 of LHX1 gene, confirming four patients with duplication (large
dup) and patient FA-275 with deletion, when compared with five unaffected controls. Patient 6498 with epilepsy shows a duplication
by quantitative PCR when compared with the mother (6840). d, Interphase FISH with LHX1 genomic probe (WIBR2-6022g13; see panel
b for location). Of the lymphocyte nuclei from affected patient 6498, 98% show evidence of tandem duplication (three signals), compared
with 28% of lymphoblast cells from the mother (6840). Two nuclei from 6840 show discordant results, with duplication present in only
one of the two cells shown, suggesting that the mother is a mosaic for the duplication (see the slight signal-intensity increase observed
in panel a).
Our results show that four of the five pediatric patients
and all three of the patients with MODY5 have deletions
that are nearly identical to that of our fetal case, with
breakpoints in all cases mapping to flanking segmental-
duplication blocks (fig. 1c). Case FR09 provides the
greatest breakpoint resolution, with a proximal breakpoint
at 31,835,000 1 kb and a distal breakpoint at 33,357,000
 1 kb defining the common minimal deletion region.
The extensive and variable copy-number polymorphism
in the flanking regions (figs. 3 and 4) and the presence of
a sequence assembly gap make it difficult to define the
breakpoints more precisely in the other three cases, but
they all occur within the large segmental duplication
blocks (proximal: 31,500,000–31,900,000 bp; distal:
33,300,000–33,600,000 bp). One case (FR35) is atypical,
with a larger de novo deletion at least 2.1 Mb in size. The
distal breakpoint is in unique sequence ∼33 kb distal to
the TCF2 gene (hg17 coordinate ∼33212500), suggesting
this deletion arose from a mechanism other than NAHR.
These results show that the 17q12 deletion is a recurrent
genomic disorder with breakpoints in flanking segmental
duplications that results in renal disease and diabetes.
Reciprocal 17q12 Duplication
We previously identified a duplication of the 17q12 region
in a patient with idiopathic mental retardation (IMR379)
and an affected sibling.7 We have identified two additional
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Figure 6. Pedigrees of three families with duplication in the
17q12 region.dupp duplication is reciprocal to 17q12 deletion;
dup* p duplication of TCF2, mosaic duplication of LHX1;
dup** p duplication of TCF2 and LHX1 (see text); FCDp focal
cortical dysplasia; MRp mental retardation. Only individuals 5812
and 6498 have had magnetic resonance imaging to evaluate for
FCD.
patients with mild-to-moderate mental retardation, epi-
lepsy, and focal cortical dysplasia who have overlapping
duplications on 17q12 by BAC array CGH (table 2). Oli-
gonucleotide microarray CGH analysis of these three in-
dividuals shows that two individuals, IMR379 and 5812,
have duplications of the entire 17q12 region, with break-
points mapping to the same duplication blocks associated
with renal disease and MODY5 deletions (fig. 5a). These
duplication events, therefore, represent the expected re-
ciprocal duplication to the common 17q12 deletion and
provide further evidence that these rearrangements are
mediated by NAHR.22 Pedigree analysis of these families
shows that dup17q12 can be stably transmitted meioti-
cally (fig. 6). The duplication is present in all affected in-
dividuals in family 1 who we were able to test. However,
apparently unaffected individuals in the family were also
found to carry the duplication, so the pathological sig-
nificance is unclear. It is possible that the duplication is
a benign copy-number variant segregating with disease in
this family. Alternatively, there may be incomplete pen-
etrance of the seizure phenotype.
To assess the frequency of the 17q12 duplication in the
general population, we analyzed a larger control group for
copy-number variation of this locus ( unrelatednp 960
white individuals who had been genotyped with a high-
density SNP Genotyping BeadChip for variable efficacy of
statin-drug response by cardiovascular disease [R. Krauss
and D. Nickerson, personal communication]). We iden-
tified a single individual with a duplication corresponding
to the 1.5-Mb region (fig. 7), whereas no individuals with
the deletion were observed. Combined with our previous
analysis of 270 HapMap individuals, this suggests a slight
enrichment of the 17q12 duplication among patients with
mental retardation and/or epilepsy (2 of 380 affected in-
dividuals; 1 of 1,276 control individuals) but does not
reach statistical significance ( , by Fisher’s exactPp .13
test).
Interestingly, the third patient (6498), who has mental
retardation, focal cortical dysplasia, and focal seizures, has
a smaller and apparently more complex duplication in
which there is a 27-kb duplication encompassing the
LHX1 gene (MIM 601999; hg17 coordinates chr17:
32360000–32387000) and a 259-kb duplication corre-
sponding to the TCF2 gene (hg17 coordinates chr17:
33122000–33381000) (fig. 5a). The mother of patient 6498
is unaffected and also carries a duplication of the TCF2
gene. However, both oligonucleotide array CGH and real-
time quantitative PCR of the 27-kb region encompassing
LHX1 suggested that the mother does not carry the LHX1
duplication (fig. 5). Interphase FISH with peripheral blood
lymphocytes from both the mother and daughter showed
that the mother is mosaic for the duplication (28% of 135
nuclei), whereas the daughter has the LHX1 duplication
in virtually all cells (98% of 138 nuclei) (fig. 5c).
Discussion
We have used a targeted approach to identify novel ge-
nomic disorders in individuals with congenital anomalies.
Our results emphasize the importance of evaluating de
novo structural-variation events in pediatric diseases other
than mental retardation and the importance of duplica-
tion architecture as a predisposing factor for disease. We
show that recurrent microdeletions of chromosome
17q12, which cause pediatric renal disease and MODY5,
are mediated by flanking segmental duplications. The
mechanism of recurrent deletion by NAHR explains the
high rate of de novo TCF2 deletions detected in previous
studies of pediatric renal disease and MODY5. Indeed, it
has been estimated that de novo structural rearrange-
ments may occur at a frequency of between 106 and 104
(100–10,000 times more frequently than de novo point
mutations).23 The 17q12 deletion is the first genomic dis-
order that results in diabetes and is the third genomic
disorder with significant renal involvement (the other two
are juvenile nephronophthisis and polycystic kidney dis-
ease). This recurrent microdeletion will have a significant
impact on diagnosis, prognosis, and management of renal
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Figure 7. A 17q12 duplication identified in 1 of 960 unaffected control samples by use of the HumanHap300 Genotyping BeadChip
(Illumina). Data show probe position (X-axis) against the log(R) intensity ratio (black) and the B-allele frequency (red) for probes on
chromosome 17. Within the limits of resolution of these data, this duplication appears to be identical to that observed in patients
IMR379 and 5812.
disease and early-onset type II diabetes in children, and
we recommend that evaluation of this microdeletion be
considered early in the diagnostic workup for children
with renal pathology.
The 17q12 deletion results in a wide range of pheno-
types with considerable variability in expressivity. Indi-
viduals with nearly identical deletions can have severe
renal disease detectable prenatally, renal disease detected
in childhood, or MODY5 (usually diagnosed before the
4th decade). Previous studies suggest that, although the
deletion is found in individuals at both ends of the phe-
notypic spectrum, those with earlier-onset disease are
more likely to have a large genomic deletion than a point
mutation in TCF2. Of those individuals with TCF2 alter-
ations in three different series, 36% of individuals who
presented with a MODY5 phenotype,12 64% of patients
ascertained in childhood with renal abnormalities,11 and
89% of patients with renal disease detected by prenatal
ultrasound (and who have not yet developed diabetes)10
had genomic deletions versus point mutations of TCF2.
These results suggest that the microdeletion is associated
with earlier onset of renal pathology. One of the genes in
the 17q12 deleted region is LHX1, a limb homeodomain
gene important for renal development in the mouse.24,25
It may be that haploinsufficiency of both TCF2 and
LHX1—two genes important for renal development—in-
fluence earlier onset of renal disease than do point mu-
tations in TCF2. However, some individuals with the de-
letion do have a milder phenotype, and individuals with
a point mutation in TCF2 may have early-onset disease;
this suggests that TCF2 is the major gene contributing to
the phenotype in patients with deletion. In addition, there
may be genetic modifiers outside the 17q12 deleted region
that contribute to the phenotype.
Interestingly, we have also identified the reciprocal du-
plication of 17q12, which may be associated with epi-
lepsy—a strikingly different phenotype than that associ-
ated with the deletion. A smaller, more complex dupli-
cation involving the TCF2 and LHX1 genes was found in
another patient with focal cortical dysplasia and epilepsy,
which suggests that one or both of these genes in the
17q12 region may be important for epilepsy and brain
development. Although the known biology of LHX1 makes
it a good candidate gene for abnormal brain development
(i.e., the gene is expressed in human brain, it is required
for migration of motor axons to the limb,26 and knockout
mice have anencephaly25), the association of the dupli-
cation with disease is less clear than that of the deletion
phenotype. Screening of 1,276 unaffected control subjects
(see the “Material and Methods” section) found a single
occurrence of this 1.5-Mb duplication (but not the recip-
rocal deletion), suggesting that this variant is rare in the
unaffected population and is enriched in patients with
mental retardation and epilepsy. One possible explanation
is incomplete penetrance of the duplication-associated
phenotype. Incomplete penetrance and variable expres-
sivity have been described for several genomic disorders,
including 22q11 deletion27 and duplication28,29 syndromes.
Additional studies will be required before a definitive as-
sociation of the variant with disease can be stated, as op-
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posed to a rare copy-number variant that fortuitously seg-
regates in some families with affected individuals.
Finally, we find that the segmental duplications located
at the breakpoints are polymorphic in copy number and
structure among unaffected individuals. Similar variation
has been noted in previous studies of genomic disorders.
We propose that this variation may contribute to the sus-
ceptibility of individual genomes to rearrangement,
wherein increased copy number in the flanking segmental
duplications increases the likelihood of NAHR. Evaluation
of parents in whom the deletion or duplication arose will
help determine the contribution of flanking polymor-
phism to genomic rearrangement.
In summary, we have found novel microdeletions and
duplications in a series of fetal samples with congenital
anomalies other than mental retardation. Combined with
recent studies of similar genetic variation in children in
mental retardation and autism,7,30,31 we put forward the
structural-variant disease hypothesis: large (1100-kb)
structural genetic changes are not uncommon in germ
cells and are more likely to be recurrent, under strong se-
lective constraint, and distributed nonrandomly in the ge-
nome. Therefore, de novo events will have a significant
impact on rare and common diseases in the population
that cannot be tracked by traditional linkage-disequilib-
rium association mapping approaches. We advocate gen-
eralized screening of genomic “hotspot” regions of both
parents and offspring for other pediatric diseases for which
the genetic etiology is not well understood (including
schizophrenia, asthma, and cardiovascular disease).
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Web Resources
The URLs for data presented herein are as follows:
Human Genome Structural Variation Project, http://humanparalogy
.gs.washington.edu/structuralvariation/ (for oligonucleotide
array data)
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for MODY5, CCL3L1, CCL4L1, TBC1D3,
TCF2, and LHX1)
PharmGKB: PARC Profile, http://www.pharmgkb.org/network/
members/parc.jsp#team
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